Abstract:BACKGROUND: The progression and persistence of myocardial ischemia/reperfusion injury (MI/RI) are strongly linked to local inflammatory responses and oxidative stress. Cyclophilin A (CypA), a pro-inflammatory factor, is involved in various cardiovascular diseases. However, the role and mechanism of action of CypA in MI/RI are still not fully understood. METHODS: We used the Gene Expression Omnibus (GEO) database for bioinformatic analysis. We collected blood samples from patients and controls for detecting the levels of serum CypA using enzyme-linked immunosorbent assay (ELISA) kits. We then developed a myocardial ischemia/reperfusion (I/R) injury model in wild-type (WT) mice and Ppia-/- mice. We utilized echocardiography, hemodynamic measurements, hematoxylin and eosin (H&E) staining, immunohistochemistry, enzyme-linked immunosorbent assay, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining to determine the role of CypA in myocardial I/R injury. Finally, we conducted an in vitrostudy, cell transfection, flow cytometry, RNA interference, and a co-immunoprecipitation assay to clarify the mechanism of CypA in aggravating cardiomyocyte apoptosis. RESULTS: We found that CypA inhibited TXNIP degradation to enhance oxidative stress-induced cardiomyocyte apoptosis during MI/RI. By comparing and analyzing CypA expression in patients with coronary atherosclerotic heart disease and in healthy controls, we found that CypA was upregulated in patients with Coronary Atmospheric Heart Disease, and its expression was positively correlated with Gensini scores. In addition, CypA deficiency decreased cytokine expression, oxidative stress, and cardiomyocyte apoptosis in I/R-treated mice, eventually alleviating cardiac dysfunction. CypA knockdown also reduced H2O2-induced apoptosis in H9c2 cells. Mechanistically, we found that CypA inhibited K48-linked ubiquitination mediated by atrophin-interacting protein 4 (AIP4) and proteasomal degradation of TXNIP, a thioredoxin-binding protein that mediates oxidative stress and induces apoptosis. CONCLUSION: These findings highlight the critical role CypA plays in myocardial injury caused by oxidative stress-induced apoptosis, indicating that CypA can be a viable biomarker and a therapeutic target candidate for MI/RI.

Potential Role of Cyclophilin A in Regulating Cytokine Secretion

Updates In Understanding The Role Of Cyclophilin A In Leukocyte Chemotaxis

Cyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy.

Delicate regulation of IL-1β-mediated inflammation by cyclophilin A

Cyclophilin A: promising target in cancer therapy

Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers

Cyclophilin A: a key player for etiological agent infection

Contribution of Cyclophilin A to the Regulation of Inflammatory Processes in Rheumatoid Arthritis

Structure,Subcellular Localization and Biological Function of Cyclophilin

The Progress of Cyclophilin A in Cancer Research

Functions of cyclophilin A in atherosclerosis.

Recent Progress and Prospects of the Study of Cyclophilins

The Role of Cyclophilins in Viral Infection and the Immune Response

Cyclophilin J Limits Inflammation Through the Blockage of Ubiquitin Chain Sensing.

Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages

Cyclophilin A Functions As an Endogenous Inhibitor for Membrane-Bound Guanylate Cyclase-A

Secreted cyclophilin A is non-genotoxic but acts as a tumor promoter

Cyclophilin A (cypa) Induces Chemotaxis Independent of Its Peptidylprolyl Cis-Trans Isomerase Activity

Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal.

The interaction between Cyclophilin A and CD147 and its clinical significance in periodontal diseases

Role of cyclophilin A in aggravation of myocardial ischemia reperfusion injury via regulation of apoptosis mediated by thioredoxin-interacting protein